期刊文献+

肿瘤型人工膝关节置换治疗儿童股骨远端骨肉瘤 被引量:5

Endoprosthetic replacement after resection of osteosarcoma at distal femur in children
原文传递
导出
摘要 目的评估使用肿瘤型人工膝关节置换治疗儿童股骨远端骨肉瘤的治疗效果。方法2003年12月至2008年12月,36例14岁以下股骨远端骨肉瘤儿童患者行肿瘤型人工膝关节置换手术,31例随访数据完整。患者年龄9~14岁,平均12.3±1.6岁。男11例,女20例。所有患者都是未经治疗的IIB期原发骨肉瘤。所有患者都经过标准术前化疗、肿瘤型人工膝关节置换手术及术后化疗。结果手术使用普通单纯铰链式膝关节8例,普通旋转铰链式膝关节11例,特制远端非水泥固定铰链式膝关节12例。边缘切除9例,广泛切除22例。31例患者随访12~75个月,中位随访时间26个月,平均32个月。随访期间死亡13例,存活18例,无瘤生存16例,带瘤生存2例。Kaplan-Meier生存分析显示2年生存率74.1%,3年生存率44.6%。局部复发2例(6.5%)。转移14例(45.2%),其中肺转移10例(32.3%),软组织或骨转移3例(9.7%),肺转移合并软组织转移或骨转移1例(3.2%)。存活且未截肢患者15例,MSTS功能评分平均21.5±4.7分,肢体功能优良率86.7%。三种假体术后功能比较,差异无显著性(P=0.979)。随访期内假体并发症发生率38.7%,其中假体周围感染2例(6.5%),假体松动10例(32.3%)。特制远端非水泥固定铰链式关节并发症低于常规使用关节。结论在标准治疗后,肺转移是导致儿童骨肉瘤患者死亡的主要原因;外科边界与局部复发关系密切,提高保肢的安全性需恰当地选择外科边界;特制远端非水泥固定铰链式人工假体与常规使用人工假体功能无明显差异,并不增加早期并发症发生率。 Objective To evaluate the effect of endoprosthetic replacement after resection of osteosarcoma at distal femur of children. Methods 36 children aged under 14 underwent endoprosthetic replacement after resection of osteosarcoma at distal femur between Dec 2003 to Dec 2008 in our center. 31 children's data were complete. Their average age was 12.3±1.6, ranging from 9 to 14. There were 11 boys and 20.girls. All the patients sustained primary osteosarcoma in stage liB without treatment in other hospital, and have undergone standard preoperative chemotherapy, endoprosthetic replacement and post-operative chemotherapy. Results 8 patients were reconstructed with hinge knee prostheses and 11 with rotational hinge knee prostheses. 12 patients were reconstructed with special hinge knee prostheses which was fixed without cement in tibial component. 9 patients underwent marginal resection and 22 underwent wide resection. 31 patients were followed up for 12 to 75 months. The median follow-up was 26 months. At the end of follow-up, 13 patients died and 18 survivied. 16 survived tumor-free and 2 survived with tumor. The 2-year survival rate was 74.1% and the 3-year survival rate was 44.6% shown by the Kaplan-Meier analysis. 2 patients had local recurrence (6.5%). 14 had metastases, 10 in the lungs, 3 in soft tissues, and 1 had combined metastases in the lungs and the soft tissues or the bones. 15 patients survived without amputation. The mean MSTS function score was 21.5±4.7. The excellent-good rate of limb fimction was 86.7%. The three prostheses were compared and the difference was not significant(P=0.979). The complication rate of prostheses was 38.7%, including peri-prosthesis infection in 2 patients(6.5%) and loosening of prostheses in 10 patients (32.3%). The special hinge knee prostheses with cementless fixation in tibial component was found to cause lower complications rate than conventional tumor knee prostheses. Conclusions After standard therapy, lung metastasis is the major cause of death. The local recurrence rate was closely related to the surgical margin. Adequate surgical margin can increase safety of limb salvage surgery. The difference between the special hinge knee prostheses and conventional tumor knee prostheses is not significant. The early complication rate is not increased in special hinge knee prostheses group.
作者 李远 牛晓辉
出处 《中国骨肿瘤骨病》 2010年第2期116-121,共6页 Chinse Journal Of Bone Tumor And Bone Disease
关键词 骨肉瘤 人工关节 重建 综合治疗 Osteosarcoma Endoprosthetic replacement Reconstruction Combined therapy
  • 相关文献

参考文献13

  • 1Enneking WF,Spanier SS,Goodman MA.A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop,1980,(153):106-120.
  • 2Enneking WF,Dunham W,Gebhardt MC.A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.Clin Orthop,1993,(286):241-248.
  • 3牛晓辉,蔡槱伯,张清,郝林,丁易.ⅡB期肢体骨肉瘤189例综合治疗临床分析[J].中华外科杂志,2005,43(24):1576-1579. 被引量:41
  • 4Kim HJ,Chalmers PN,Morris CD.Pediatric osteogenic sarcoma.Curr Opin Pediatr,2010,22:61-66.
  • 5蔡槱伯,牛晓辉,张清,郝林,刘文生,鱼锋.肢体原发成骨肉瘤综合治疗的远期结果[J].中华外科杂志,2000,38(5):329-331. 被引量:34
  • 6Bacci G,Fomi C,Ferrari S.Neoadjuvant chemotherapy for osteosarcoma of the extremity:intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.J Pediatr Hematol Oncol,2003,25:845-853.
  • 7Plotz W,Rechl H,Burgkart R,et al.Limb salvage with tumor endoprostheses for malignant tumors of the knee.Clin Orthop Relat Res,2002,(405):207-215.
  • 8Frink SJ,Rutledge J,Lewis VO,et al.Favorable longterm results of prosthetic arthroplasty of the knee for distal femur neoplasms.Clin Orthop Relat Res,2005,(438):65-70.
  • 9Eckardt JJ,Kabo JM,Kelley CM,et al.Expandable endoprosthesis reconstruction in skeletally immature patients with tumors.Clin Orthop,2000,373:51-61.
  • 10Neel MD,Wilkins RM,Rao BN,et al.Early multicenter experience with a noninvasive expandable prosthesis.Clin Orthop Relat Res,2003,415:72-81.

二级参考文献12

  • 1宋献文,中华外科杂志,1984年,22卷,129页
  • 2Enneking WF,Spanier SS,Goodman MA.A system for the surgical staging of musculoskeletal sarcoma.Clin Orthop,1980,(153):106-120.
  • 3Enneking WF,Dunham W,Gebhardt MC.A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.Clin Orthop,1993,(286):241-248.
  • 4Bacci G,Forni C,Ferrari S.Neoadjuvant chemotherapy for osteosarcoma of the extremity:intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.J Pediatr Hematol Oncol,2003,25:845-853.
  • 5Batsakis JG. Surgical excision margins: pathologist' s perspective. Adv Anat Pathol, 1999, 6:140-148.
  • 6Damron TA, Pritchard DJ. Current combined treatment of high- grade osteosarcomas. Oncology, 1995, 9:327-343.
  • 7Virkus WW, Marshall D, Enneking WF, et al. The effect of contaminated surgical margins revisited. Clin Orthop Relat Res, 2002 ( 397 ) : 89 -94
  • 8Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res. 2003 (415) :4-18.
  • 9Matsumoto S, Kawaguchi N, Manabe J, et al. Surgical treatment for bone and soft tissue sarcoma . Gan To Kagaku Ryoho, 2004, 31:1314-1318.
  • 10Kawaguchi N, Ahmed AR, Matsumoto S, et al. The concept of curative margin in surgery for bone and soft tissue sarcoma. Clin Orthop Relat Res, 2004 (419) : 165-172.

共引文献92

同被引文献40

  • 1楼燕凤,曹爽,王蔚雯.62例膝关节周围骨肉瘤人工肿瘤型假体置换术的护理[J].医学研究生学报,2011,24(5):526-529. 被引量:19
  • 2汤小东,郭卫,杨荣利,杨毅,姬涛.儿童及青少年膝关节周围骨肉瘤的保肢治疗[J].中华外科杂志,2007,45(10):669-672. 被引量:9
  • 3于秀淳,刘晓平,周银,付志厚,宋若先,孙海宁,徐明.保留骨骺灭活再植术治疗儿童骨肉瘤应注意的问题[J].中华小儿外科杂志,2007,28(8):422-425. 被引量:3
  • 4邱贵兴,戴越戎.骨科手术学[M].第三版.北京:人民卫生出版社,2005.347.
  • 5Marina N,Gebhardt M, Teot L, et al. Biology and therapeutic advances for pediatric osteosarcoma [J ]. Oncologist, 2004, 9 (4) :422-441.
  • 6Enneking WF, Dunham W, Gebhardt MC,et al. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system [J]. Clin Orthop Relat Res, 1993, (286) :241-246.
  • 7Kinkel S, Lehner B, Kleinhans JA, et al. Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses[J]. J Surg Oncol, 2010,101(2) : 166-169.
  • 8Kim H J, Chalmers PN, Morris CD. Pediatric osteogenic sarcoma [J]. Curr Opin Pediatr, 2010, 22(1) : 61-66.
  • 9BacciG, Longhi A, Fagioli F, et al. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy [J]. Eur J Cancer, 2005, 41(18): 2836-2845.
  • 10RamseierLE, Malinin TI, Temple HT, et al. Allograft reconstruction for bone sarcoma of the tibia in the growing child[J]. J Bone Joint Surg Br,2006,88(1):95-99.

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部